+1 347 708 0418
Glanzmann Thrombasthenia Therapeutic Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Glanzmann Thrombasthenia Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin
Segment by Application
Hospital
Clinic
Others
By Company
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Platelet Transfusion
1.2.3 Recombinant Activated Factor VII
1.2.4 Antifibrinolytics
1.2.5 Fibrin Sealants
1.2.6 Thrombin
1.2.7 Desmopressin
1.3 Market by Application
1.3.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Perspective (2017-2028)
2.2 Glanzmann Thrombasthenia Therapeutic Drug Growth Trends by Region
2.2.1 Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Region (2017-2022)
2.2.3 Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Region (2023-2028)
2.3 Glanzmann Thrombasthenia Therapeutic Drug Market Dynamics
2.3.1 Glanzmann Thrombasthenia Therapeutic Drug Industry Trends
2.3.2 Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
2.3.3 Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
2.3.4 Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue
3.1.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue (2017-2022)
3.1.2 Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Players (2017-2022)
3.2 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glanzmann Thrombasthenia Therapeutic Drug Revenue
3.4 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio
3.4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2021
3.5 Glanzmann Thrombasthenia Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Type
4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Type (2017-2022)
4.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2023-2028)
5 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Application
5.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Application (2017-2022)
5.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2017-2028)
6.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
6.2.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022)
6.2.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028)
6.2.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2017-2028)
6.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
6.3.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022)
6.3.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028)
6.3.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2017-2028)
6.4 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
6.4.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022)
6.4.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size (2017-2028)
7.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
7.2.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022)
7.2.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028)
7.2.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2017-2028)
7.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
7.3.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022)
7.3.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028)
7.3.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2017-2028)
7.4 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
7.4.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022)
7.4.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size (2017-2028)
8.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2017-2028)
9.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
9.2.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022)
9.2.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028)
9.2.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2017-2028)
9.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
9.3.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022)
9.3.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028)
9.3.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2017-2028)
9.4 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
9.4.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022)
9.4.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size (2017-2028)
10.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.1.4 Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.1.5 Novo Nordisk Recent Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.2.5 Alnylam Pharmaceuticals Recent Developments
11.3 Shire (Takeda)
11.3.1 Shire (Takeda) Company Details
11.3.2 Shire (Takeda) Business Overview
11.3.3 Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.3.4 Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.3.5 Shire (Takeda) Recent Developments
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.4.4 Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.4.5 Biogen Recent Developments
11.5 Bioverativ (Sanofi)
11.5.1 Bioverativ (Sanofi) Company Details
11.5.2 Bioverativ (Sanofi) Business Overview
11.5.3 Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.5.4 Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.5.5 Bioverativ (Sanofi) Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.6.4 Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.6.5 Bayer Recent Developments
11.7 CSL Behring
11.7.1 CSL Behring Company Details
11.7.2 CSL Behring Business Overview
11.7.3 CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.7.4 CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.7.5 CSL Behring Recent Developments
11.8 Grifols
11.8.1 Grifols Company Details
11.8.2 Grifols Business Overview
11.8.3 Grifols Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.8.4 Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.8.5 Grifols Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.9.4 Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.10.4 Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
11.10.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Platelet Transfusion
Table 3. Key Players of Recombinant Activated Factor VII
Table 4. Key Players of Antifibrinolytics
Table 5. Key Players of Fibrin Sealants
Table 6. Key Players of Thrombin
Table 7. Key Players of Desmopressin
Table 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2017-2022)
Table 12. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2023-2028)
Table 14. Glanzmann Thrombasthenia Therapeutic Drug Market Trends
Table 15. Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
Table 16. Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
Table 17. Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
Table 18. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Share by Players (2017-2022)
Table 20. Global Top Glanzmann Thrombasthenia Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2021)
Table 21. Ranking of Global Top Glanzmann Thrombasthenia Therapeutic Drug Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
Table 25. Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2017-2022)
Table 29. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2023-2028)
Table 31. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Share by Application (2017-2022)
Table 33. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Share by Application (2023-2028)
Table 35. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 65. Novo Nordisk Company Details
Table 66. Novo Nordisk Business Overview
Table 67. Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Product
Table 68. Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 69. Novo Nordisk Recent Developments
Table 70. Alnylam Pharmaceuticals Company Details
Table 71. Alnylam Pharmaceuticals Business Overview
Table 72. Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Product
Table 73. Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 74. Alnylam Pharmaceuticals Recent Developments
Table 75. Shire (Takeda) Company Details
Table 76. Shire (Takeda) Business Overview
Table 77. Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Product
Table 78. Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 79. Shire (Takeda) Recent Developments
Table 80. Biogen Company Details
Table 81. Biogen Business Overview
Table 82. Biogen Glanzmann Thrombasthenia Therapeutic Drug Product
Table 83. Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 84. Biogen Recent Developments
Table 85. Bioverativ (Sanofi) Company Details
Table 86. Bioverativ (Sanofi) Business Overview
Table 87. Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Product
Table 88. Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 89. Bioverativ (Sanofi) Recent Developments
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Glanzmann Thrombasthenia Therapeutic Drug Product
Table 93. Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 94. Bayer Recent Developments
Table 95. CSL Behring Company Details
Table 96. CSL Behring Business Overview
Table 97. CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Product
Table 98. CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 99. CSL Behring Recent Developments
Table 100. Grifols Company Details
Table 101. Grifols Business Overview
Table 102. Grifols Glanzmann Thrombasthenia Therapeutic Drug Product
Table 103. Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 104. Grifols Recent Developments
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Product
Table 108. Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 109. Bristol-Myers Squibb Recent Developments
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Glanzmann Thrombasthenia Therapeutic Drug Product
Table 113. Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022) & (US$ Million)
Table 114. Pfizer Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type: 2021 VS 2028
Figure 2. Platelet Transfusion Features
Figure 3. Recombinant Activated Factor VII Features
Figure 4. Antifibrinolytics Features
Figure 5. Fibrin Sealants Features
Figure 6. Thrombin Features
Figure 7. Desmopressin Features
Figure 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2021 VS 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Glanzmann Thrombasthenia Therapeutic Drug Report Years Considered
Figure 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region: 2021 VS 2028
Figure 16. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players in 2021
Figure 17. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2021
Figure 19. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 21. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 22. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 23. United States Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 27. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 28. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 29. Germany Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Region (2017-2028)
Figure 39. China Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 49. Mexico Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Country (2017-2028)
Figure 55. Turkey Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Novo Nordisk Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 60. Shire (Takeda) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 61. Biogen Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 62. Bioverativ (Sanofi) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 63. Bayer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 64. CSL Behring Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 65. Grifols Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 67. Pfizer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Buy
